JOHNSON & JOHNSON ADVANCED CARE PRODUCTS OTC HDL CHOLESTEROL TEST
This article was originally published in The Gray Sheet
Executive SummaryJOHNSON & JOHNSON ADVANCED CARE PRODUCTS OTC HDL CHOLESTEROL TEST expected to sell at a premium to the $15-20 suggested retail price for the Advanced Care total cholesterol test, according to test manufacturer ChemTrak. ChemTrak announced Aug. 29 that it had signed an agreement granting J&J subsidiary ACP rights to the OTC version of the high density lipoprotein test. The pact expands on an existing agreement between the firms for the OTC version of ChemTrak's total cholesterol test, which was launched by ACP in June ("The Gray Sheet" Jan. 17, p. 6).
You may also be interested in...
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.